0
0
Read Time:4 Minute, 21 Second
The Artificial Intelligence (AI) in Medical Diagnostics Market is projected to reach $9.38 billion by 2029, growing at a compound annual growth rate (CAGR) of 36.2% from 2022 to 2029. This growth is primarily fueled by the increasing demand for AI in medical diagnosis, the shortage of healthcare professionals, and the rising prevalence of chronic diseases. However, hesitancy to adopt AI technologies due to trust concerns limits market expansion. Despite these challenges, the market holds high growth potential, particularly in emerging economies, with numerous cross-industry partnerships expected to further drive opportunities. Key obstacles remain, including regulatory hurdles and privacy and security concerns.
Leading Companies in the AI in Medical Diagnostics Market
- Siemens Healthineers AG (Germany)
Founded in 1847 and headquartered in Erlangen, Germany, Siemens Healthineers AG provides healthcare solutions through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. With over 63 AI-powered solutions, the company automates and standardizes workflows and complex diagnostics, catering to hospitals, clinics, labs, universities, public health agencies, insurers, pharmaceutical companies, and clinical research institutes. Siemens Healthineers has a presence in 180 countries and production sites in the U.S., China, and Germany. - GE Healthcare (U.S.)
A subsidiary of General Electric, GE Healthcare, founded in 1892 and based in Massachusetts, U.S., offers solutions in medical imaging, diagnostics, therapeutic manufacturing, patient monitoring, and drug discovery. The company’s AI-driven Edison healthcare platform connects data across millions of medical imaging devices, with applications in diagnostics. Operating in over 160 countries, GE Healthcare supports hospitals, research institutions, and life sciences centers globally. - Aidoc Medical Ltd. (Israel)
Established in 2016 in Tel Aviv, Aidoc Medical Ltd. specializes in AI tools for radiologists and response teams. Its solutions analyze medical imaging to detect acute abnormalities and prioritize critical findings in CT scans, enhancing efficiency for radiologists. Aidoc’s software is implemented in over 900 locations globally, and it has received nine FDA approvals for AI-based solutions, securing awards like the UCSF Digital Health Award (2021).
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5312
- HeartFlow Inc. (U.S.)
Headquartered in California and founded in 2010, HeartFlow Inc. develops solutions for cardiovascular diagnostics. Its FFRCT Analysis uses deep learning to generate a 3D model of a patient’s arteries, aiding in coronary artery disease (CAD) diagnosis. HeartFlow’s products are available in the U.S., Europe, Canada, and Japan, earning recognition as one of Fast Company’s “World’s Most Innovative Companies.” - AliveCor, Inc. (U.S.)
AliveCor, established in 2010 in California, offers mobile ECG solutions for detecting atrial fibrillation (AF) and other cardiac conditions. Its Kardia Mobile and Kardia Pro AI-enabled platform provide accurate, proactive cardiac care, recording over 85 million ECGs globally. AliveCor received $65 million in Series E funding in 2020 to expand its remote cardiology platform. - Koninklijke Philips N.V. (Netherlands)
Founded in 1891 and based in Amsterdam, Koninklijke Philips N.V. operates in diagnostic imaging, therapy, patient monitoring, and health informatics through its Diagnostics & Treatment segment. With a global reach across mature and growth regions, Philips focuses on AI-based diagnostic solutions. Its Diagnostics & Treatment division employs over 32,000 people globally. - Digital Diagnostics Inc. (U.S.)
Founded in 2010 in Iowa, U.S., Digital Diagnostics Inc. (formerly IDx) offers autonomous AI diagnostic solutions, including IDx-DR, an FDA-cleared system for diabetic retinopathy and macular edema diagnosis. The company’s products are utilized in over 20 health systems and are recognized for autonomous AI-driven disease detection in primary care. - NovaSignal Corporation (U.S.)
Based in California, NovaSignal, founded in 2013, provides robotic cerebral ultrasound systems combining AI, robotics, and ultrasound technology to assess cerebral blood flow in real-time. NovaSignal’s systems are used across the U.S. and Europe, with $71 million raised to support product innovation and clinical trials. - Arterys Inc. (U.S.)
Founded in 2013 and headquartered in California, Arterys provides a web-based AI imaging platform for clinical diagnostics, receiving the first-ever U.S. FDA clearance for AI-based cloud computing in 2017. Its products support faster and more accurate diagnoses, backed by Series C funding of $28 million in 2020. - Agfa HealthCare (Belgium)
A division of the Agfa-Gevaert Group, Agfa HealthCare, established in 1964 in Belgium, provides AI-driven imaging and IT solutions in radiology and healthcare. Agfa’s global operations span North America, Europe, and Asia, delivering healthcare IT and imaging solutions to enhance diagnostics and patient care.
Buy Now: https://www.meticulousresearch.com/Checkout/71255048
Noteworthy Mentions:
- Riverain Technologies (U.S.)
- Imagen Technologies (U.S.)
- VUNO Inc. (South Korea)
- NANO-X IMAGING LTD (Israel)
- iSchemaView Inc. (U.S.)
- AIRS Medical Inc. (South Korea)
- Claritas HealthTech Pte. Ltd. (Singapore)
- Quantitative Insights, Inc. (U.S.)
- Ultromics Ltd. (U.K.)
- ClariPi, Inc. (South Korea)
- Pulmonx Corporation (U.S.)
- IBM Corporation (U.S.)
Contact Us:
Meticulous Market Research Pvt. Ltd.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
Email– sales@meticulousresearch.com
USA: +1-646-781-8004
Europe: +44-203-868-8738
APAC: +91 744-7780008
Visit Our Website: https://www.meticulousresearch.com/
For Latest Update Follow Us:
LinkedIn– https://www.linkedin.com/company/meticulous-research
Meticulous Blog | Top Market Research Reports Blog – https://meticulousblog.org/
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %